Institute of Medical Biology (IMB)
For the first time, researchers have generated lab-grown livers that have functioning bile canaliculi, an important step towards modeling complex liver diseases.
A genetic cause for anencephaly, a common neural tube defect found in developing fetuses, has been identified for the first time.
A novel genomic biomarker may help to meet the demand for donor mesenchymal stem cells in regenerative medicine.
Flower-like ‘rosettes’ may help malaria parasites evade the body’s immune defences.
A microRNA called miR-355 has been identified as the key regulator of skin cell differentiation in patients with atopic dermatitis.
Researchers at A*STAR have discovered how a class of small proteins is essential for metabolism.
An international consortium gives a debilitating childhood disorder a name and a genetic cause.
Clinicians and scientists have discovered a rare mutation that impairs the immune system, and are using their findings to devise treatment strategies
A*STAR scientists have uncovered a novel surface marker that identifies stem cells and potential cancer stem cells in the distal stomach.
By enhancing stem cell proliferation, this newly developed bio-additive lowers the barriers to regenerative medicine.
Modifying how embryonic stem cells use sugar can switch them into a totipotent state, A*STAR researchers say.
DNA damage associated with premature aging in Hutchinson-Gilford Progeria Syndrome can be prevented if the abnormal protein progerin is removed before DNA replication.